StonvexLoading…
StonvexStonvexStonvexCore line items from AMRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $1.77B | $1.37B | $1.82B | $1.22B |
Operating Income | $108.75M | $82.22M | $132.99M | $95.43M |
Net Income | $56.76M | $62.47M | $94.93M | $70.46M |
EPS (Diluted) | $1.07 | $1.17 | $1.78 | $1.35 |
Total Assets | $4.16B | $3.71B | $2.88B | $2.22B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $108.52M | $79.27M | $115.53M | $50.45M |
Free Cash Flow OCF − CapEx | $113.31M | $-75.70M | $-343.58M | $-177.19M |
Shares Outstanding | 53.14M | 53.23M | 53.28M | 52.27M |